Infection Control & Hospital Epidemiology
8. Baur D, Gladstone BP, Burkert F, et al. Effect of antibiotic stewardship on the incidence of infection and colonisation with antibiotic-resistant bacteria and Clostridium difficile infection: a systematic review and meta- analysis. Lancet Infect Dis 2017;17:990–1001.
9. Joint Commission Perspectives, July 2016, vol. 36, issue 7. Oakbrook Terrace, IL: The Joint Commission; 2016.
10. Snyder GM, Patel PR, Kallen AJ, Strom JA, Tucker JK, D’Agata EM. Antimicrobial use in outpatient hemodialysis units. Infect Control Hosp Epidemiol. 2013;34:349–357.
11. Hui K, Nalder M, Buising K, et al. Patterns of use and appropriateness of antibiotics prescribed to patients receiving haemodilaysis: an observational study. BMC Nephrol 2017;18:156.
12. Snyder G, Patel PR, Kallen AJ, Strom JA, Tucker JK, D’Agata EMC. Factors associated with the receipt of antimicrobials among chronic hemodialysis patients. Am J Infect Control 2016;44:1269–1274.
13. Central line-associated bloodstream infection (CLABSI) event. Centers for Disease Control and Prevention website.
http://www.cdc.gov/nhsn/ TOC_PSCManual.html. Published 2012. Accessed August 25, 2018.
14. Clinical practice guidelines for vascular access. Am J Kidney Dis 0062;48 Suppl 1:S176–S247.
15. Clinical practice guidelines for vascular access. Am J Kidney Dis 2006;48 Suppl 1:S248–S273.
16. Nicolle LE, Bradley S, Colgan R, Rice JC, Schaeffer A, Hooton TM. Infectious Diseases Society of America guidelines for the diagnosis and treatment of asymptomatic bacteriuria in adults. Clin Infect Dis 2005;9:643–654.
17. Mandell LA, Wunderink RG, Anzueto A, et al. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis 2007;44 Suppl 2:S27–S72.
18. Stevens DL, Bisno AL, Chambers HF, et al. Practice guidelines for the diagnosis and management of skin and soft-tissue infections. Clin Infect Dis 2005;41:1373–1406.
19. Recommendations for preventing the spread of vancomycin resistance. Recommendations of the Hospital Infection Control Practices Advisory Committee (HICPAC). MMWR Recomm Rep 1995;44(RR-12):1–13.
20. High KP, Bradley SF, Gravenstein S, et al. Clinical practice guideline for the evaluation of fever and infection in older adult residents of long-term care facilities: 2008 update by the Infectious Diseases Society of America. Clin Infect Dis 2009;48:149–171.
21. Solomkin JS, Mazuski JE, Bradley JS et al. Diagnosis and management of complicated intra-abdominal infection in adults and children: guidelines by the Surgical Infection Society and the Infectious Diseases Society of America. Surg Infect (Larchmt) 2010;11:79–109.
22. Anderson DJ, Sexton DJ. Overview of control measures to prevent surgical site infection. In: Harris A, ed. UpToDate.Waltham, MA: Wolters Kluwer Health; 2012.
23. Gupta K, Hooton TM, Naber KG et al. International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: a 2010 update by the Infectious Diseases
1405
Society of America and the European Society for Microbiology and Infectious Diseases. Clin Infect Dis 2011;52:e103–e120.
24. Hooton TM, Bradley SF, Cardenas DD, et al. Diagnosis, prevention, and treatment of catheter-associated urinary tract infection in adults: 2009 International Clinical Practice Guidelines from the Infectious Diseases Society of America. Clin Infect Dis 2010;50:625–663.
25. Mackowiak PA, Wasserman SS, Levine MM. A critical appraisal of 98.6°F, the upper limit of the normal body temperature, and other legacies of Carl Reinhold August Wunderlich. JAMA 1992;268:1578–1580.
26. Dellinger EP, Gross PA, Barrett TL, et al. Quality standard for antimicrobial prophylaxis in surgical procedures. Infectious Diseases Society of America. Clin Infect Dis 1994;18:422–427.
27. Pascale RS. The power of positive deviance: how unlikely innovators solve the world’s toughest problems. Boston: Harvard Business School Press. 2010.
28. Downham G, Jones E, Peterson P, et al. Reducing bloodstream infections in an outpatient hemodialysis center—New Jersey, 2008–2011. Morb Mort Weekly Rep 2012;61:169–173.
29. Lindberg C, Downham G, Buscell P, Jones E, Peterson P, Krebs V. Embracing collaboration: a novel strategy for reducing blood stream infections in outpatient dialysis centers. Am J Infect Control 2013:41:513–519.
30. Schweizer ML, Braun BI, Milstone AM. Research methods in healthcare epidemiology and antimicrobial stewardship-quasi-experimental designs. Infect Control Hosp Epidemiol 2016;37:1135–1140.
31. Wagner AK, Soumerai SB, Zhang F, Ross-Degnan D. Segmented regression analysis of interrupted time series studies in medication use research. J Clin Pharm Ther 2012;27:299–330.
32. Schweizer ML, Furuno JP, Harris AD et al. Comparative effectiveness of nafcillin versus vancomycin in methicillin-susceptible Staphylococcus aureus bacteremia. BMC Infect Dis 2011;11:279–286.
33. Stryjewski ME, Szczech LA, Benjamin DK, et al. Use of vancomycin or first-generation cephalosporins for the treatment of hemodialysis- dependent patients with methicillin-susceptible Staphylococcus aureus bacteremia. Clin Infect Dis 2007;44:190–196.
34. Chan KE, Warren HS, Thadhani RI, et al. Prevalence and outcomes of antimicrobial treatment for Staphylococcus aureus bacteremia in out- patients with ESRD. J Am Soc Nephrol 2012;23:1551–1559.
35. Saely S, Kaye KS, Fairfax MR, Chopra T, Pogue JM. Investigating the impact of the definition of previous antibiotic exposure related to isolation of extended spectrum β-lactamase–producing Klebsiella pneumoniae. Am J Infect Control 2011;39:390–395.
36. Cunha CB, D’Agata EMC. Antimicrobial stewardship in out-patient dialysis units. Curr Opin Nephrol Hypertens 2016;25:551–555.
37. Dellit TH, Owens RC, McGowan JE, et al. Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance anti- microbial stewardship. Clin Infect Dis 2007;44:159–177.
38. D’Agata EMC. Addressing the problem of multidrug-resistant organisms in dialysis facilities. Clin J Amer Soc Nephrol 2018 (in press).
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80 |
Page 81 |
Page 82 |
Page 83 |
Page 84 |
Page 85 |
Page 86 |
Page 87 |
Page 88 |
Page 89 |
Page 90 |
Page 91 |
Page 92 |
Page 93 |
Page 94 |
Page 95 |
Page 96 |
Page 97 |
Page 98 |
Page 99 |
Page 100 |
Page 101 |
Page 102 |
Page 103 |
Page 104 |
Page 105 |
Page 106 |
Page 107 |
Page 108 |
Page 109 |
Page 110 |
Page 111 |
Page 112 |
Page 113 |
Page 114 |
Page 115 |
Page 116 |
Page 117 |
Page 118 |
Page 119 |
Page 120 |
Page 121 |
Page 122 |
Page 123 |
Page 124
